Most Read Articles
6 days ago
Combining the DASH (Dietary Approaches to Stop Hypertension) diet with low sodium intake reduces systolic blood pressure (SBP) in individuals with pre- and stage 1 hypertension, with progressively higher reductions at greater levels of baseline SBP, a recent study has shown.
Tristan Manalac, 4 days ago
Major depressive disorder (MDD) appears to be more prevalent in females than in males, particularly in those who are divorced or widowed, a recent study from Singapore has found.
5 days ago
Tadalafil may not be effective for reducing the decline in ambulatory ability in boys with Duchenne muscular dystrophy (DMD), as shown in a recent study.
01 Dec 2017
At a symposium during the 25th Congress of the Obstetrical and Gynaecological Society of Malaysia in Kuala Lumpur, Professor Susan Davis discussed the unique implications of women living decades beyond menopause, and how healthcare professionals can best manage menopausal symptoms in the short and long term.

Hyperkalaemia on admission tied to higher mortality in heart failure

02 Oct 2017

Serum potassium concentrations greater than 5.5 mEq/L at admission is independently correlated with elevated short- and long-term mortality in heart failure (HF) patients, a recent study suggests.

The study included 4,031 heart failure patients, 83 percent (n=3,349) of whom had low-normal potassium levels at admission, 11 percent (n=461) had borderline-high levels and 6 percent (n=221) had hyperkalaemia. Patients without serum potassium measurements at admission were excluded.

Hyperkalaemia patients had significantly higher unadjusted 30-day mortality rates compared with low-normal potassium patients (13 vs 7 percent; p=0.002). However, after adjusting for comorbidities, gender and age, the significant relationship was attenuated (hazard ratio [HR], 1.57; 95 percent CI, 0.73 to 3.35).

According to Kaplan-Meier survival analysis, hyperkalaemia and borderline-high potassium patients had significantly higher rates of 1-year all-cause mortality than those with low-normal potassium (40 vs 34 vs 27 percent, respectively; log rank p<0.01).

Adjusting for comorbidities, age and gender showed that only hyperkalaemia remained significantly related to 1-year mortality risk (HR, 1.51; 1.04 to 2.2), while borderline-high potassium levels did not (HR, 0.79; 0.57 to 1.09).

Ten-year all-cause mortality rates were also significantly higher in patients with hyperkalaemia and borderline-high potassium levels than in those with low-normal potassium levels (92 vs 88 vs 82 percent, respectively; log rank p<0.001). The difference between hyperkalaemia and borderline-high potassium level patients also reached significance (p=0.016).

Similarly, multivariate analysis adjusted for age, gender and comorbidities found that only hyperkalaemia was associated with higher all-cause mortality (HR, 1.31; 1.035 to 1.66; p=0.025), while borderline-high potassium was not (HR, 0.985; 0.83 to 1.16; p=0.86).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
6 days ago
Combining the DASH (Dietary Approaches to Stop Hypertension) diet with low sodium intake reduces systolic blood pressure (SBP) in individuals with pre- and stage 1 hypertension, with progressively higher reductions at greater levels of baseline SBP, a recent study has shown.
Tristan Manalac, 4 days ago
Major depressive disorder (MDD) appears to be more prevalent in females than in males, particularly in those who are divorced or widowed, a recent study from Singapore has found.
5 days ago
Tadalafil may not be effective for reducing the decline in ambulatory ability in boys with Duchenne muscular dystrophy (DMD), as shown in a recent study.
01 Dec 2017
At a symposium during the 25th Congress of the Obstetrical and Gynaecological Society of Malaysia in Kuala Lumpur, Professor Susan Davis discussed the unique implications of women living decades beyond menopause, and how healthcare professionals can best manage menopausal symptoms in the short and long term.